CDC panel endorses Pfizer COVID-19 vaccine for children 12 and up
An advisory panel for the U.S. Centers for Disease Control and Prevention voted Wednesday to endorse the Pfizer-BioNTech COVID-19 vaccine for older children ages 12 to 15.
An advisory panel for the U.S. Centers for Disease Control and Prevention voted Wednesday to endorse the Pfizer-BioNTech COVID-19 vaccine for older children ages 12 to 15.